These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 12655444)

  • 21. Virulizin induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors.
    Benatar T; Cao MY; Lee Y; Li H; Feng N; Gu X; Lee V; Jin H; Wang M; Der S; Lightfoot J; Wright JA; Young AH
    Cancer Immunol Immunother; 2008 Dec; 57(12):1757-69. PubMed ID: 18351336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative.
    Hollingshead M; Alley M; Burger AM; Borgel S; Pacula-Cox C; Fiebig HH; Sausville EA
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):115-25. PubMed ID: 15791458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
    Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
    Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electroporation enhances therapeutic efficacy of anticancer drugs: treatment of human pancreatic tumor in animal model.
    Nanda GS; Sun FX; Hofmann GA; Hoffman RM; Dev SB
    Anticancer Res; 1998; 18(3A):1361-6. PubMed ID: 9673341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y; Harada K; Ferdous T; Yoshida H
    Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of the quinocarmycins KW2152 and DX-52-1 against human melanoma lines growing in culture kand in mice.
    Plowman J; Dykes DJ; Narayanan VL; Abbott BJ; Saito H; Hirata T; Grever MR
    Cancer Res; 1995 Feb; 55(4):862-7. PubMed ID: 7850800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical efficacy of the camptothecin-polymer conjugate IT-101 in multiple cancer models.
    Schluep T; Hwang J; Cheng J; Heidel JD; Bartlett DW; Hollister B; Davis ME
    Clin Cancer Res; 2006 Mar; 12(5):1606-14. PubMed ID: 16533788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NK cell activation and tumor infiltration are involved in the antitumor mechanism of Virulizin.
    Cao MY; Lee Y; Feng N; Li H; Du C; Miao D; Li J; Lee V; Jin H; Wang M; Gu X; Wright JA; Young AH
    Cancer Immunol Immunother; 2005 Mar; 54(3):229-42. PubMed ID: 15378281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virulizin(R) - A review of its antineoplastic activity.
    Ferdinandi ES; Braun DP; Liu C; Zee BC; Ely G
    Expert Opin Investig Drugs; 1999 Oct; 8(10):1721-1735. PubMed ID: 11139822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of tumour growth and of response to chemotherapy of human melanomas in athymic, nude mice.
    Fodstad O; Aass N; Pihl A
    Br J Cancer Suppl; 1980 Apr; 4():146-9. PubMed ID: 6932918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy of a human malignant melanoma transplanted in the nude mouse.
    Povlsen CO; Jacobsen GK
    Cancer Res; 1975 Oct; 35(10):2790-6. PubMed ID: 1157050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor action of bovine seminal ribonuclease. Cytostatic effect on human melanoma and mouse seminoma.
    Poucková P; Soucek J; Jelínek J; Zadinová M; Hlousková D; Polívková J; Navrátil L; Cinátl J; Matousek J
    Neoplasma; 1998; 45(1):30-4. PubMed ID: 9604999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-tumor efficacy of the nucleoside analog 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl) cytosine (4'-thio-FAC) in human pancreatic and ovarian tumor xenograft models.
    Zajchowski DA; Biroc SL; Liu HL; Chesney SK; Hoffmann J; Bauman J; Kirkland T; Subramanyam B; Shen J; Ho E; Tseng JL; Dinter H
    Int J Cancer; 2005 May; 114(6):1002-9. PubMed ID: 15645422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intratumoral chemotherapy with a sustained-release drug delivery system inhibits growth of human pancreatic cancer xenografts.
    Smith JP; Stock E; Orenberg EK; Yu NY; Kanekal S; Brown DM
    Anticancer Drugs; 1995 Dec; 6(6):717-26. PubMed ID: 8845483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of various therapeutic solutions including colloidal chromic 32P via an intratumoral injection on the tumor physiological parameters of AsPC-1 human pancreatic tumor xenografts in nude mice.
    Lee I; Lee YH
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3139s-3142s. PubMed ID: 10541354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human fibroblast interferon in human neoplasia: clinical and laboratory study.
    Horoszewicz JS; Leong SS; Ito M; Buffett RF; Karakousis C; Holyoke E; Job L; Dölen JG; Carter WA
    Cancer Treat Rep; 1978 Nov; 62(11):1899-906. PubMed ID: 728909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to chemotherapy of human, malignant melanoma xenografts in athymic, nude mice.
    Fodstad O; Aass N; Pihl A
    Int J Cancer; 1980 Apr; 25(4):453-8. PubMed ID: 7372371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Trials on expanding the clinical application of cisplatin].
    Ogawa M
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1004-10. PubMed ID: 3551845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.